Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions.
Journal
medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986
Informations de publication
Date de publication:
13 Nov 2023
13 Nov 2023
Historique:
pubmed:
24
10
2023
medline:
24
10
2023
entrez:
24
10
2023
Statut:
epublish
Résumé
Randomised controlled trials (RCTs) inform healthcare decisions. It is now apparent that some published RCTs contain false data and some appear to have been entirely fabricated. Systematic reviews are performed to identify and synthesise all RCTs that have been conducted on a given topic. While it is usual to assess methodological features of the RCTs in the process of undertaking a systematic review, it is not usual to consider whether the RCTs contain false data. Studies containing false data therefore go unnoticed and contribute to systematic review conclusions. The INSPECT-SR project will develop a tool to assess the trustworthiness of RCTs in systematic reviews of healthcare related interventions. The INSPECT-SR tool will be developed using expert consensus in combination with empirical evidence, over five stages: 1) a survey of experts to assemble a comprehensive list of checks for detecting problematic RCTs, 2) an evaluation of the feasibility and impact of applying the checks to systematic reviews, 3) a Delphi survey to determine which of the checks are supported by expert consensus, culminating in 4) a consensus meeting to select checks to be included in a draft tool and to determine its format, 5) prospective testing of the draft tool in the production of new health systematic reviews, to allow refinement based on user feedback. We anticipate that the INSPECT-SR tool will help researchers to identify problematic studies, and will help patients by protecting them from the influence of false data on their healthcare.
Identifiants
pubmed: 37873409
doi: 10.1101/2023.09.21.23295626
pmc: PMC10593010
pii:
doi:
Types de publication
Preprint
Langues
eng
Subventions
Organisme : NEI NIH HHS
ID : U01 EY020522
Pays : United States
Organisme : NEI NIH HHS
ID : UG1 EY020522
Pays : United States
Déclaration de conflit d'intérêts
Declaration of interests JW, CH, GA, LB, JJK declare funding from NIHR (NIHR203568) in relation to this work. LB additionally declares The University of Colorado receives remuneration for service as Senior Research Integrity Editor, Cochrane. WL, ALS, and RW declare funding from Australian National Health and Medical Research Council Investigator Grants (GNT2016729, GNT2009432, GNT2009767). EF, SG, TLa declare employment by Cochrane. Tla additionally declares authorship of a chapter in the Cochrane Handbook for Systematic Reviews of Interventions and that he is a developer of standards for Cochrane intervention reviews (MECIR). ES declares that she was a member of the Cochrane scientific misconduct policy advisory group. ZA declares he is a member of the Cochrane Library Editorial Board, and PI on a grant from Children Investment Foundation Fund to University of Liverpool to investigate research integrity of clinical trials related to nutritional supplements in pregnancy. TLi is supported by grant UG1 EY020522 from the National Eye Institute, National Institutes of Health. MC declares that he is Co-ordinating Editor for the Cochrane Methodology Review Group. AA declares that The Health Services Research Unit, University of Aberdeen, is funded by the Health and Social Care Directorates of the Scottish Government.
Références
Arch Intern Med. 2006 Jun 26;166(12):1256-61
pubmed: 16801507
Cochrane Database Syst Rev. 2020 Aug 12;8:CD007407
pubmed: 32794606
Cochrane Database Syst Rev. 2021 Jun 3;6:ED000152
pubmed: 34081324
Res Synth Methods. 2023 May;14(3):357-369
pubmed: 36054583
Open Forum Infect Dis. 2021 Jul 06;8(11):ofab358
pubmed: 34796244
BJOG. 2016 Oct;123(11):1745-52
pubmed: 27558956
Open Forum Infect Dis. 2022 Jan 17;9(2):ofab645
pubmed: 35071686
J Clin Epidemiol. 2021 Aug;136:189-202
pubmed: 34033915
J Clin Epidemiol. 2022 Nov;151:1-17
pubmed: 35850426
BMJ. 2019 Aug 28;366:l4898
pubmed: 31462531
Res Integr Peer Rev. 2023 Jun 20;8(1):6
pubmed: 37337220
BMJ. 2008 May 3;336(7651):995-8
pubmed: 18456631
JAMA Intern Med. 2018 Aug 1;178(8):1135
pubmed: 30083732
Nat Med. 2021 Nov;27(11):1853-1854
pubmed: 34552263
Am J Ther. 2021 Jun 21;28(4):e434-e460
pubmed: 34145166
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
Nature. 2020 Jan;577(7789):167-169
pubmed: 31911697